跳至主要内容
临床试验/NCT06125860
NCT06125860已完成不适用

Targeting Strategies of Antenatal Balanced Energy and Protein Supplementation in Addis Ababa, Ethiopia

Harvard School of Public Health (HSPH)2 个研究点 分布在 1 个国家目标入组 7,851 人开始时间: 2023年8月7日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
7,851
试验地点
2
主要终点
Small-for-gestational-age births

研究概览

简要总结

The goal of this randomized effectiveness study is to evaluate the different targeting strategies for the delivery of balanced energy and protein (BEP) supplements among pregnant women in Addis Ababa, Ethiopia. The main goals of the study are to: 1) determine the effectiveness of two individual-based antenatal BEP targeting strategies for preventing adverse pregnancy outcomes; 2) compare the cost-effectiveness of the universal BEP provision with two individual-based targeting strategies for preventing adverse pregnancy outcomes; and 3) generate implementation evidence regarding the feasibility and acceptability of different antenatal BEP targeting strategies. Pregnant women will be enrolled during pregnancy, assigned to different strategies of BEP supplementation, and followed from pregnancy through six weeks postpartum to evaluate the impacts of different BEP targeting strategies on pregnancy, maternal, and child outcomes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 49 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • pregnant women aged 18 to 49;
  • attending antenatal visits in one of the study health facilities;
  • with a gestational age of 24 weeks or less;
  • no known allergies to peanuts or soybeans;
  • having resided in the current location for at least 6 months;
  • intending to continue antenatal follow-up in the health facility;
  • intending to give birth and remain in the study area until six weeks after delivery; and
  • willing to take the BEP supplements for the entire duration of the pregnancy if eligible.

排除标准

  • Not meeting all of the inclusion criteria above

研究组 & 干预措施

Arm 4 (universal BEP)

Experimental

干预措施: Universal BEP (Dietary Supplement)

Arm 3 (Targeted BEP by baseline nutritional status and monthly gestational weight gain monitoring)

Experimental

干预措施: Targeted BEP based on baseline nutritional status and monthly GWG monitoring (Dietary Supplement)

Arm 1 (control arm)

No Intervention

In Arm 1 (control arm), participants will receive the standard of antenatal care including iron and folic acid supplementation.

Arm 2 (Targeted BEP based on baseline nutritional status)

Experimental

干预措施: Targeted BEP based on baseline nutritional status (Dietary Supplement)

结局指标

主要结局

Small-for-gestational-age births

时间窗: Assessed within 72 hours of birth

Live birth whose birthweight for sex and gestational age is \< 10th percentile based on the INTERGROWTH-21st standards

次要结局

  • Macrosomia(Assessed within 72 hours of birth)
  • Pre-eclampsia(After 20 weeks of gestation)
  • Stillbirth(Between 28 weeks of gestation and delivery)
  • Preterm birth(Less than 37 completed weeks of gestation)
  • Neonatal death(From birth through 28 days of life)
  • Perinatal death(Between 28 weeks of gestation to 7 days after delivery)
  • Inadequate gestational weight gain(At the last weight measurement before delivery, at around 36 weeks)
  • Excessive gestational weight gain(At the last weight measurement before delivery, at around 36 weeks)
  • Large-for-gestational-age births(Assessed within 72 hours of birth)
  • Low birthweight(Assessed within 72 hours of birth)
  • Third-trimester anemia(At 32 weeks of gestation)

研究者

发起方
Harvard School of Public Health (HSPH)
申办方类型
Other
责任方
Principal Investigator
主要研究者

Wafaie Fawzi

Richard Saltonstall Professor of Population Sciences, and Professor of Nutrition, Epidemiology, and Global Health

Harvard School of Public Health (HSPH)

研究点 (2)

Loading locations...

相似试验

进行中(未招募)
不适用
Energy Balance Interventions in Increasing Physical Activity in Breast Cancer Gene Positive Patients, Lynch Syndrome-Positive Patients, CLL Survivors or High-Risk Family MembersBody Mass Index 25 or GreaterBRCA1 Gene MutationBRCA2 Gene MutationBreast CarcinomaCancer SurvivorFatigueHealth Status UnknownLynch SyndromeOvarian CarcinomaOverweightChronic Lymphocytic Leukemia
NCT02194387M.D. Anderson Cancer Center337
已完成
不适用
The Energy Flux StudyPhysical Activity
NCT01736098University of South Carolina81
已完成
2 期
Evaluation of Risk-Adapted and MRD-Driven Strategy for Untreated Fit Patients With Intermediate Risk Chronic Lymphocytic LeukemiaIntermediate Risk Chronic Lymphocytic LeukemiaFit PatientsRisk-Adapted and MRD-Driven Strategy
NCT04010968French Innovative Leukemia Organisation120
已完成
2 期
Lifestyle Program (Scalable Nutrition and Physical Activity) for the Improvement of Nutrition and Physical Activity in Stage 0-III Breast Cancer SurvivorsAnatomic Stage 0 Breast Cancer AJCC v8Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8Anatomic Stage IIB Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8Anatomic Stage IIIC Breast Cancer AJCC v8Prognostic Stage 0 Breast Cancer AJCC v8Prognostic Stage I Breast Cancer AJCC v8Prognostic Stage IA Breast Cancer AJCC v8Prognostic Stage IB Breast Cancer AJCC v8Prognostic Stage II Breast Cancer AJCC v8Prognostic Stage IIA Breast Cancer AJCC v8Prognostic Stage IIB Breast Cancer AJCC v8Prognostic Stage III Breast Cancer AJCC v8Prognostic Stage IIIA Breast Cancer AJCC v8Prognostic Stage IIIB Breast Cancer AJCC v8Prognostic Stage IIIC Breast Cancer AJCC v8
NCT04200482Fred Hutchinson Cancer Center90
已完成
不适用
Intervention by Midwife to Address the Fear of ChildbirthFear of Childbirth
NCT05000203University of Las Palmas de Gran Canaria214